696 related articles for article (PubMed ID: 27686492)
1. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.
Ho WL; Hsu WM; Huang MC; Kadomatsu K; Nakagawara A
J Hematol Oncol; 2016 Sep; 9(1):100. PubMed ID: 27686492
[TBL] [Abstract][Full Text] [Related]
2. Differential N-Glycosylation Patterns in Lung Adenocarcinoma Tissue.
Ruhaak LR; Taylor SL; Stroble C; Nguyen UT; Parker EA; Song T; Lebrilla CB; Rom WN; Pass H; Kim K; Kelly K; Miyamoto S
J Proteome Res; 2015 Nov; 14(11):4538-49. PubMed ID: 26322380
[TBL] [Abstract][Full Text] [Related]
3. Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.
Thomas D; Rathinavel AK; Radhakrishnan P
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188464. PubMed ID: 33157161
[TBL] [Abstract][Full Text] [Related]
4. Glycosylation characteristics of colorectal cancer.
Holst S; Wuhrer M; Rombouts Y
Adv Cancer Res; 2015; 126():203-56. PubMed ID: 25727149
[TBL] [Abstract][Full Text] [Related]
5. Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet.
Hockl PF; Wolosiuk A; Pérez-Sáez JM; Bordoni AV; Croci DO; Toum-Terrones Y; Soler-Illia GJ; Rabinovich GA
Pharmacol Res; 2016 Jul; 109():45-54. PubMed ID: 26855319
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen.
Fu C; Zhao H; Wang Y; Cai H; Xiao Y; Zeng Y; Chen H
HLA; 2016 Dec; 88(6):275-286. PubMed ID: 27679419
[TBL] [Abstract][Full Text] [Related]
7. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.
Taniguchi N; Kizuka Y
Adv Cancer Res; 2015; 126():11-51. PubMed ID: 25727145
[TBL] [Abstract][Full Text] [Related]
8. Glycobiology Modifications in Intratumoral Hypoxia: The Breathless Side of Glycans Interaction.
Silva-Filho AF; Sena WLB; Lima LRA; Carvalho LVN; Pereira MC; Santos LGS; Santos RVC; Tavares LB; Pitta MGR; Rêgo MJBM
Cell Physiol Biochem; 2017; 41(5):1801-1829. PubMed ID: 28376491
[TBL] [Abstract][Full Text] [Related]
9. O-glycan recognition and function in mice and human cancers.
Cervoni GE; Cheng JJ; Stackhouse KA; Heimburg-Molinaro J; Cummings RD
Biochem J; 2020 Apr; 477(8):1541-1564. PubMed ID: 32348475
[TBL] [Abstract][Full Text] [Related]
10. Cell surface protein glycosylation in cancer.
Christiansen MN; Chik J; Lee L; Anugraham M; Abrahams JL; Packer NH
Proteomics; 2014 Mar; 14(4-5):525-46. PubMed ID: 24339177
[TBL] [Abstract][Full Text] [Related]
11. Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.
Ferdosi S; Rehder DS; Maranian P; Castle EP; Ho TH; Pass HI; Cramer DW; Anderson KS; Fu L; Cole DEC; Le T; Wu X; Borges CR
J Proteome Res; 2018 Jan; 17(1):543-558. PubMed ID: 29129073
[TBL] [Abstract][Full Text] [Related]
12. Immature truncated O-glycophenotype of cancer directly induces oncogenic features.
Radhakrishnan P; Dabelsteen S; Madsen FB; Francavilla C; Kopp KL; Steentoft C; Vakhrushev SY; Olsen JV; Hansen L; Bennett EP; Woetmann A; Yin G; Chen L; Song H; Bak M; Hlady RA; Peters SL; Opavsky R; Thode C; Qvortrup K; Schjoldager KT; Clausen H; Hollingsworth MA; Wandall HH
Proc Natl Acad Sci U S A; 2014 Sep; 111(39):E4066-75. PubMed ID: 25118277
[TBL] [Abstract][Full Text] [Related]
13. Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation.
Yin B; Gao Y; Chung CY; Yang S; Blake E; Stuczynski MC; Tang J; Kildegaard HF; Andersen MR; Zhang H; Betenbaugh MJ
Biotechnol Bioeng; 2015 Nov; 112(11):2343-51. PubMed ID: 26154505
[TBL] [Abstract][Full Text] [Related]
14. On the trail of the glycan codes stored in cancer-related cell adhesion proteins.
Hoja-Łukowicz D; Przybyło M; Duda M; Pocheć E; Bubka M
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3237-3257. PubMed ID: 27565356
[TBL] [Abstract][Full Text] [Related]
15. How glycosylation affects glycosylation: the role of N-glycans in glycosyltransferase activity.
Mikolajczyk K; Kaczmarek R; Czerwinski M
Glycobiology; 2020 Dec; 30(12):941-969. PubMed ID: 32363402
[TBL] [Abstract][Full Text] [Related]
16. Aberrant glycosylation as biomarker for cancer: focus on CD43.
Tuccillo FM; de Laurentiis A; Palmieri C; Fiume G; Bonelli P; Borrelli A; Tassone P; Scala I; Buonaguro FM; Quinto I; Scala G
Biomed Res Int; 2014; 2014():742831. PubMed ID: 24689054
[TBL] [Abstract][Full Text] [Related]
17. Glycobiology of cellular expiry: Decrypting the role of glycan-lectin regulatory complex and therapeutic strategies focusing on cancer.
Kumar Das A; Ghosh N; Mandal A; Sil PC
Biochem Pharmacol; 2023 Jan; 207():115367. PubMed ID: 36481348
[TBL] [Abstract][Full Text] [Related]
18. Glycosylation: a hallmark of cancer?
Vajaria BN; Patel PS
Glycoconj J; 2017 Apr; 34(2):147-156. PubMed ID: 27975160
[TBL] [Abstract][Full Text] [Related]
19. Overview of Characterizing Cancer Glycans with Lectin-Based Analytical Methods.
Pearson AJ; Gallagher ES
Methods Mol Biol; 2019; 1928():389-408. PubMed ID: 30725466
[TBL] [Abstract][Full Text] [Related]
20. Altered N-Glycan expression profile in epithelial-to-mesenchymal transition of NMuMG cells revealed by an integrated strategy using mass spectrometry and glycogene and lectin microarray analysis.
Tan Z; Lu W; Li X; Yang G; Guo J; Yu H; Li Z; Guan F
J Proteome Res; 2014 Jun; 13(6):2783-95. PubMed ID: 24724545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]